Experience

Artisan Bio

• United States
• Biotechnology Research
• 1 - 100 Employee

• Associate Director, Genome Analytics

  • Jul 2023 - Present

• Senior Scientist II, Genome Analytics

  • Mar 2023 - Jul 2023

• Senior Scientist, NGS

  • Oct 2021 - Feb 2023



Arpeggio Biosciences

• United States
• Biotechnology
• 1 - 100 Employee

• Assay Development Lead

  • Mar 2020 - Oct 2021

  Lead the development of nascent RNA sequencing assays. Define novel use-cases of our NGS-based platforms for external partners.

• Scientist

  • Feb 2018 - Mar 2020

  Established and operationalized transcriptomic and NGS-based platforms for a new biotech startup. Designed and executed feasibility and proof-of-concept studies for external engagements.



University of Colorado Boulder

• United States
• Higher Education
• 700 & Above Employee

• Postdoctoral Research Associate

  • Sep 2017 - Feb 2018

• Graduate Research Assistant

  • Aug 2011 - Aug 2017

  Conducting research on understanding signaling pathways regulating retinal development in cell culture and mouse models. Determining the specificity and requirement of protein interactions within these signaling pathways.



Idaho State University

• Higher Education
• 700 & Above Employee

• Research Assistant

  • Jun 2005 - Jul 2011

  I conducted research on a drug discovery project that exploits natural compounds as potential anticancer and chemopreventative agents. I worked with both in vitro and in vivo models extensively. I conducted toxicological studies testing the natural compounds with intraperitoneal-injected mice. Additionally, I studied the tumorogenicity of various cancer cell lines subcutaneously injected into athymic mice with specified treatments. This project required me to collaborate with two companies… Show more I conducted research on a drug discovery project that exploits natural compounds as potential anticancer and chemopreventative agents. I worked with both in vitro and in vivo models extensively. I conducted toxicological studies testing the natural compounds with intraperitoneal-injected mice. Additionally, I studied the tumorogenicity of various cancer cell lines subcutaneously injected into athymic mice with specified treatments. This project required me to collaborate with two companies overseas: it prompted me to further develop my communication and management skills. In parallel, I worked on a project determining the nanotoxicity of various metallic oxide nanoparticles in human and mouse cell lines. We collaborated with other groups to identify size-specific toxicities of nanoparticles. Show less I conducted research on a drug discovery project that exploits natural compounds as potential anticancer and chemopreventative agents. I worked with both in vitro and in vivo models extensively. I conducted toxicological studies testing the natural compounds with intraperitoneal-injected mice. Additionally, I studied the tumorogenicity of various cancer cell lines subcutaneously injected into athymic mice with specified treatments. This project required me to collaborate with two companies… Show more I conducted research on a drug discovery project that exploits natural compounds as potential anticancer and chemopreventative agents. I worked with both in vitro and in vivo models extensively. I conducted toxicological studies testing the natural compounds with intraperitoneal-injected mice. Additionally, I studied the tumorogenicity of various cancer cell lines subcutaneously injected into athymic mice with specified treatments. This project required me to collaborate with two companies overseas: it prompted me to further develop my communication and management skills. In parallel, I worked on a project determining the nanotoxicity of various metallic oxide nanoparticles in human and mouse cell lines. We collaborated with other groups to identify size-specific toxicities of nanoparticles. Show less